Post categorized under: Pooled SARS-CoV-2 Surveillance
All too often in the conversation COVID-19 testing, two factors are lost: Pragmatism and Cost. Our Microarray platform can deliver highly effective Pooled Surveillance that can provide an early warning among groups at a dramatically lower cost than individual testing. The world is coming around to our way of thinking. Explore this promising area in the fight against the pandemic.
- Study outlines limitations of nasopharyngeal swab dependence, calls for pooled surveillance
A study published in the lancet discusses how reliance upon the nasal swab performed by medical professionals isn’t likely to provide the coverage needed as we enter flu season. Read the full article »
- Duke University reports a .5% positive rate using pooled testing
Demonstrating the use case for low-prevalence population, Duke revealed the latest results of the pooled surveillance COVID-19 regimen. Saving valuable reagents, Duke has employed pooled surveillance testing for asymptomatic students since August 2nd. More here »